Compare CDMOs specializing in biologics drug product formulation, aseptic fill-finish, and packaging for vials, syringes, and autoinjectors.
161 companies listed
United States
Forge Biologics, acquired by Ajinomoto Group in 2023 for $554-620 million, is a gene therapy CDMO specializing in high-purity adeno-associated virus (AAV) vector and plasmid manufacturing. The company operates a 200,000 sq ft Hearth facility in Columbus, Ohio with 20 cGMP suites and 20,000L bioreactor capacity, providing end-to-end services from preclinical process development through commercial manufacturing.
China
GenScript ProBio is a leading biologics CDMO and subsidiary of GenScript Biotech Corporation, providing end-to-end services from discovery to commercialization. The company has raised $224 million in C-round funding, operates GMP plasmid and viral vector manufacturing facilities in Hopewell, New Jersey and Nanjing, China, and has established a manufacturing facility in Singapore. GenScript ProBio specializes in antibody discovery, cell and gene therapy manufacturing, and biologics development.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.